Two doses of triprolidine for treatment of allergic rhinitis.

Abstract	Two doses of triprolidine (2.5 mg t.i.d. and 1.25 mg t.i.d.) were compared with placebo in 32 patients suffering from allergic rhinitis. Triprolidine 2.5 mg t.i.d. was statistically significantly better than placebo (p less than 0.05) in reducing the symptoms of sneezing and eye irritation. Neither dose of triprolidine produced significant drowsiness during the second week of treatment.
Authors	M G Britton, D W Empey, G C John, M Hodder, D T Hughes
Journal	Annals of allergy (Ann Allergy) Vol. 42 Issue 5 Pg. 330-2 (May 1979) ISSN: 0003-4738 [Print] United States
PMID	378040 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References	Pyridines Triprolidine
Topics	Adolescent Adult Clinical Trials as Topic Dose-Response Relationship, Drug Double-Blind Method Female Humans Male Middle Aged Pyridines (therapeutic use) Rhinitis, Allergic, Seasonal (drug therapy) Sleep Stages Triprolidine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!